期刊文献+

DSCT对PCI术后管腔再狭窄的诊断价值 被引量:1

THE VALUE OF DSCT IN THE DIAGNOSIS OF RESTENOSIS OF CORONARY ARTERY AFTER PCI
下载PDF
导出
摘要 目的评估双源CT(DSCT)冠状动脉成像检查对冠心病冠状动脉支架置入术(PCI)术后病人支架内管腔再狭窄的诊断价值。方法 2012年4—12月,选取就诊于我院心脑血管分院的冠心病PCI术后病人98例,进行DSCT冠状动脉成像检查,以选择性冠状动脉造影(CAG)为标准,观察其诊断的灵敏度、特异度及准确性。结果 DSCT冠状动脉成像对冠状动脉支架内管腔情况显示良好,显示PCI术后管腔再狭窄与CAG检查相比差异无统计学意义(P>0.05),其诊断的灵敏度为87.8%,特异度为95.7%,准确性为93.4%,阳性预测值为92.8%,阴性预测值为91.3%。结论 DSCT冠状动脉成像作为一种方便、经济、安全、无创的检查手段,可作为冠心病PCI术后病人定期复查、预后评估及管腔再狭窄筛查的有效方法。 Objective To evaluate the value of dual-source CT (DSCT) in the diagnosis of restenosis of coronary artery after PCI in patients with coronary heart disease (CHD). Methods From April to December 2012, patients with CHD after PCI were enrolled for coronary artery imaging using DSCT to observe its sensitivity, specificity and accuracy by comparing with the finding of selective coronary angiogram (SCA). Results DSCT coronary imaging clearly demonstrated the lumen in which the stent indwelled, indicating that the incidence of restenosis was not significantly different as compared with SCA (P〉0.05), its diagnostic sensitivity, specificity and accuracy was 87.8%, 95.7% and 93.4%, respectively; its positive and negative predictive value was 92.8% and 91.3%, respectively. Conclusion Being a convenient, economical, safe, and noninvasive means of examination, DSCT can be used as an effective method to periodically recheck CHD patients after PCI, predict their prognosis and screen the restenosis of the coronary artery.
出处 《齐鲁医学杂志》 2014年第2期139-141,共3页 Medical Journal of Qilu
关键词 体层摄影术 X线计算机 支架 移植物闭塞 血管 诊断 tomography, X-ray computed stents graft occlusion, vascular diagnosis
  • 相关文献

参考文献3

二级参考文献16

  • 1Havdhammax PA, van Beusekom HM, Emanuelsson HU, et al. Reduction in thrimbitic events with heparin-coated Palmaz-schatz stent in normal porcine coronary artery[J]. Circulation, 1996,93(3):423-430.
  • 2Toheng JE. Glycoprotein II b/III a receptor inhibitors : putting the EPIC IMPACT II , RESTORE,and EPILOG trails into perspective[J]. Am J Cardiol, 1996,78(3A):35-40.
  • 3Anonymous. Randomized placebo-controlled trail of effect of eptilibatide on complications of percutaneous coronary intervention : IMPACT-II Integrilin to Minimize platelet Aggregation and Coronary Thrombosis-II[J] . Lancet, 1997,349(9063):1422-1428.
  • 4Treasure CB, Klein JL,Weintraub WS,et al. Benifical effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease[J]. NEJM, 1995,332(8):481-487.
  • 5Jukema JW, Bruschke AVG, van Broven A J, et al. ON behalf to the REGRESS study group, Inter University Cardiology Institute Utrecht,the Netherlands. Effects of Lipid Lowerlngby pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated senn cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)[J]. Circulation, 1995,91(10):2528-2540.
  • 6Jorgensen B, Simonsen S, Endresen K, et ol. Restenosis and clinical outcome in patients treated with Amlodipine after angioplasty: results from CAPARES[J].Am Coil Cardiol, 2000,35(3):592-599.
  • 7Tulenko TN, Brown J, Laury-Kleintop L, et al. Atheroprotection with amlodipine:cells to lesions and the PREVENT trial[J]. J Cardiovasc Parmacol, 1999,33[Suppl 2]:S17-S22.
  • 8Eickelberg O, Roth M ,Block LH. Effects of amlodipine on gene expression and extracellular matrix formation in human vascular smooth muscle cells and fibmblasts: implication for vascular protection[J]. Int J Cardiol, 1997,62[Suppl 2]:S31-S37.
  • 9Watanabe K, Sekiya M, Ikeda S, et al. Prevention effects of probucol on restenosis after percutaneous transluminal coronary angioplasty[J]. Am Heart J,1996,132(1 Pt 1):23.
  • 10Tarif JC, Cote G, Lesperance J, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty[J]. N Engl J Med,1997,337(6):365.

共引文献26

同被引文献10

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部